Exploring your options for Hemophilia Management in India? Ginger Healthcare brings together a carefully chosen panel of reputed hematologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Hemophilia Management. Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Here are the most reputed hospitals in India for Hemophilia Management. These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Hemophilia is a lifelong inherited bleeding disorder in which the blood cannot clot properly due to a deficiency in clotting factor VIII (Hemophilia A) or factor IX (Hemophilia B). Without adequate clotting factors, even minor injuries can lead to prolonged bleeding, and spontaneous bleeds into joints and muscles can cause progressive, irreversible damage over time. Modern hemophilia care has transformed outcomes dramatically — today, most people with hemophilia live active, productive lives through a combination of factor replacement therapy, newer non-factor biologics, and emerging gene therapy. The right treatment approach depends on the type and severity of hemophilia, whether inhibitors are present, the patient's age, and what is available in their country of care. A specialist hemophilia team coordinates long-term management, bleed prevention, joint health, and monitoring.
Intravenous infusions of the missing clotting factor given at the time of a bleed to stop it quickly — suited to mild or moderate hemophilia patients who bleed infrequently.
Estimated cost: ~$200 – $500
Typical tests: CBC with differential, Activated partial thromboplastin time (aPTT), Clotting factor VIII or IX activity assay, Inhibitor screen (Bethesda assay), PT/INR, Liver function tests (LFT), Hepatitis B and C serology, HIV serology. Done in India before admission.
Estimated cost in India: $1,500 – $5,000
Treatment duration in India: ~7 days (~3 hospital visit days across the full span)
Regular scheduled intravenous or subcutaneous infusions to maintain clotting factor levels above a protective threshold — the global standard of care for severe hemophilia to prevent joint damage.
Estimated cost: ~$500 – $1,000
Typical tests: CBC with differential, Activated partial thromboplastin time (aPTT), Clotting factor VIII or IX activity assay (trough and peak), Inhibitor screen (Bethesda assay), Pharmacokinetic profiling (serial factor level measurements), PT/INR, Liver function tests (LFT), Hepatitis B and C serology, HIV serology, Joint ultrasound or X-ray (affected joints). Done in India before admission.
Estimated cost in India: $3,000 – $10,000
Treatment duration in India: ~2 weeks (~5 hospital visit days across the full span)
A weekly, fortnightly, or monthly subcutaneous injection that mimics the role of factor VIII without needing intravenous access — especially valuable for children, patients with inhibitors, and those with difficult venous access.
Estimated cost: ~$500 – $1,000
Typical tests: CBC with differential, Clotting factor VIII activity assay, Inhibitor screen (Bethesda assay), aPTT (baseline — note: aPTT is prolonged on emicizumab; chromogenic assay preferred for monitoring), Chromogenic factor VIII assay (for baseline and monitoring), Liver function tests (LFT), Hepatitis B and C serology, HIV serology. Done in India before admission.
Estimated cost in India: $4,000 – $12,000
Treatment duration in India: ~2 weeks (~4 hospital visit days across the full span)
Specialist management for patients who have developed antibodies against factor concentrate, using bypassing agents to control bleeds and immune tolerance induction to eliminate the inhibitor over time.
Estimated cost: ~$500 – $1,500
Typical tests: CBC with differential, aPTT and PT/INR, Clotting factor VIII or IX activity assay, Bethesda assay with Nijmegen modification (inhibitor titer), von Willebrand factor antigen and activity, Liver function tests (LFT), Hepatitis B and C serology, HIV serology, Joint imaging (X-ray or ultrasound of affected joints). Done in India before admission.
Estimated cost in India: $5,000 – $20,000
Treatment duration in India: ~3 weeks (~7 hospital visit days across the full span)
A single intravenous infusion that delivers a working copy of the clotting factor gene to liver cells, enabling the body to produce its own factor — potentially reducing or eliminating the need for ongoing treatment for years.
Estimated cost: ~$1,500 – $2,500
Typical tests: CBC with differential, Clotting factor VIII or IX activity assay, Inhibitor screen (Bethesda assay), AAV capsid antibody neutralisation assay (vector-specific eligibility test), Liver function tests (LFT) — baseline and serial, Liver ultrasound or fibroscan (baseline liver health assessment), Hepatitis B and C serology and viral load, HIV serology, PT/INR and aPTT, ECG and cardiology clearance. Done in India before admission.
Estimated cost in India: $20,000 – $35,000
Pre-procedure stay (outside hospital): ~7 days
Hospitalisation: ~5 days
Recovery period (outside hospital): ~21 days recommended
Total stay: approx 33 days
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
